Sign Up to like & get
recommendations!
0
Published in 2019 at "SLAS Discovery"
DOI: 10.1177/2472555219879644
Abstract: Nicotinamide mononucleotide adenylyltransferase (NMNAT; EC 2.7.7.1) catalyzes the reversible production of NAD+ from NMN+ and ATP and is a potential drug target for cancer and neurodegenerative diseases. A sensitive bioluminescent assay format suitable to high-throughput…
read more here.
Keywords:
nicotinamide mononucleotide;
adenylyltransferase nmnat;
throughput screening;
bioluminescent ... See more keywords